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Group 2 includes individuals who were likely to have been
exposed to M. tuberculosis infections (HRG).
Results: Overall agreement between IFN-gamma assay
and TST was 89.3% (kappa = 0.052). In LRG, agreement
between the two tests was 52.6% (95% conﬁdence interval,
44—60%) with  values of 0.019. In HRG agreement between
the two tests was 63.2% (95% conﬁdence interval, 42—84%)
with  values of 0.28.
Conclusion: In conclusion, the IFN-gamma assay showed
acceptable results for determining latent M. tuberculo-
sis infection in vaccinated population. Although TST and
IFN-gamma assay appear comparable, they have differ-
ent performance and operational characteristics; therefore,
the decision to select one test over the other will
depend on the population, purpose of testing, and resource
availability.
doi:10.1016/j.ijid.2008.05.848
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Background: A Fluoroquinolone (FQN) is the drug of ﬁrst
choice for the treatment of multi-drug resistant tuber-
culosis (MDR TB) but the FQN-resistance rate in Vietnam
is unknown. A rapid and effective test to detect FQN-
resistance before treatment is urgently needed. FQNs inhibit
the function of the DNA gyrase, encoded by the gyrAB
genes of Mycobacterium tuberculosis and mutations in the
Quinolone Resistance Determining Region (QRDR) of gyrA
have been shown to account for 60—70% of FQN-resistant
isolates. A Real-time-PCR (RT-PCR) test was developed to
detect the most common mutations in this region.
Methods: gyrA sequencing data from 40 FQN-sensitive
and 42 FQN-resistant (oﬂoxacin 2g/ml) clinical isolates
was used to develop the RT-PCR test. Three Locked-Nucleic-
Acid probes were used to detect mutations at codons 90,
91 or 94 which accounted for 97% of the FQN-related muta-
tions in QRDR of gyrA. A set of 131 consecutive isolates from
retreatment patients from Pham Ngoc Thach Hospital, resis-
tant to either Isoniazid or Rifampin, was used to evaluate the
RT-PCR and estimate the resistance rate.
Results: Sequencing data showed that all 40 FQN-
sensitive isolates were wild-type in the QRDR. Among 42
FQN-resistant isolates, 10 were wild-type, 20 carried single
mutations and, surprisingly, 12 were heterogeneous contain-
ing both wild-type and mutated populations. Of these 12,
4 contained a mutation at 2 resistance-associated alleles.
The RT-PCR test identiﬁed all wild-type and single muta-
tion isolates correctly and 12/16mutations in heterogeneous
isolates. Five percent of isolates (7/131) from retreatment
patients were identiﬁed as FQN-resistant by RT-PCR and con-
ﬁrmed by sequencing.
Conclusion: This RT PCR assay is a quick, relatively simple
and cheap test to screen for FQN-resistance with 100% speci-
ﬁcity. FQN resistance is estimated at > 5% in retreatment
patients in Southern Vietnam. Studies to determine other
FQN-resistance mechanisms are vital to improve molecular
diagnosis and treatment.
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Background: The aim of the present study was to assess
progress made in the diagnosis of pulmonary tuberculo-
sis when evaluating B-cell responses to 16 Ag85A synthetic
peptides, the recombinant antigen 85 (rAg85) and the non-
recombinant PPD antigen.
Methods: The B-cell responses of tuberculosis patients
and healthy individuals were evaluated by an IgG-ELISA. A
total of 120 individuals were included in this study. Patient
groups were conformed of 20 Warao indigenous (WP) and 20
Creole non-indigenous (CP), whilst healthy control groups
were composed by 40 Warao indigenous (WC) and 40 Creole
non-indigenous (CC). Both control groups included 20 posi-
tive and 20 negative individuals for the tuberculin skin test
(TST). Association of positive tests for each antigen, deﬁned
with receiver operator characteristics (ROC) analysis, was
assessed for each population.
Results: Different patterns of the B-cell responses
were displayed by each population. The anti-29878 IgG
method reached highest sensitivity of 95.0% (negative pre-
dictive value (NPV) = 94.4) within the Warao population,
but was lowly speciﬁc, 42.5%, (positive predictive value
(PPV) = 45.2), compared to highest speciﬁcity showed by
the anti-29879 IgG method (100.0%, PPV = 100). Regarding
the Creole population, anti-11006 IgG showed highest sen-
sitivity of 95.0% (NPV = 90) but was lowly speciﬁc (22.5%,
PPV = 38). Anti-10998 IgG was found to be the most spe-
ciﬁc (100.0%, PPV = 100), followed by the anti-PPD IgG
method (90.0%, PPV = 66.7). These ﬁndings indicate that
population-to-population heterogeneity of peptide antigen
recognition, rather than recognition of particular antigens,
is a characteristic feature of antibody responses in these two
populations. Furthermore, responses to anti-29879 IgG and
anti-10998 IgG were associated to inactive TB.
Conclusion: Ag85A peptides were more speciﬁc than sen-
sitive, showing that these peptides’ high speciﬁcity does not
stimulate primed T cells in TST+ individuals, suggesting that
